Alzheimer's Disease Related Dementias (ADRD) was mainly considered a global health issue in high-income countries, but this perception is rapidly changing, with recent projections indicating that by 2050, 70% of dementia cases will be in low- and middle-income countries – with Africa contributing a considerable proportion of these.

DAC’s ‘6×5’ plan was recently featured in this piece from Think Global Health.

The Davos Alzheimer’s Collaborative (DAC), a worldwide initiative to prevent Alzheimer’s and improve brain health, today announced the publication of a new paper in Nature Medicine.

Teams Expand Research Across Africa; Advance Early Detection and Accurate Diagnosis, and Build Healthcare System Capacity

George Vradenburg joined the Progress, Possibilities, and Potential podcast to preview DAC’s presence at AAIC, an upcoming Africa brain health plan release, and more.

Chi‑Udeh‑Momoh, Fernando Johann, Vaibhav Narayan, Irene B. Meier, and Karen Blackmon are featured in this piece from the Global Brain Health Institute.

DAC is highlighted in this piece from the World Economic Forum, spotlighting new advances in the fight against Alzheimer’s Disease.

WASHINGTON, D.C. — JUNE 3 —The introduction of the Global Alzheimer’s Initiative Now (GAIN) Act marks an important step forward in the American fight against one of our greatest health challenges, touching a majority of American families and costing America over $360 billion annually.

The Spring Meeting of the DAC Healthcare System Preparedness Learning Laboratory, 7 May 2025

The partnership supports a Global Project to Advance Alzheimer’s Disease Research in North Africa, with an international team aiming to develop better understanding of Alzheimer’s disease and dementia in diverse populations

The Davos Alzheimer’s Collaborative (DAC) Healthcare System Preparedness program is proud to announce the launch of the Early Detection Demonstration Project in the UK, as an addition to the ongoing READ-OUT study. This initiative will integrate digital cognitive assessments alongside cutting-edge blood biomarker tests, aiming to improve early and accurate diagnosis of Alzheimer’s disease and related dementias.

DAVOS – With populations ageing and mental health disorders at a record high, halting the global “pandemic” of brain disorders needs to be a paramount concern of industry – as well as the global health community.

What is needed is a global effort spawning a “healthy brain economy” for the future, reflecting the same sense of commitment and investments as those displayed in preventing childhood diseases.

DAVOS, SWITZERLAND, January 20, 2025 - The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to advance brain health and resilience throughout life, today announced that Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), will deliver a keynote speech at the DAC Brain House on Tuesday, January 21, at 2:30 p.m. CET, at the World Economic Forum Annual Meeting (WEF) in Davos, Switzerland.

DAVOS, SWITZERLAND, January 17, 2025 - The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to prevent Alzheimer’s disease, today announced the Brain House, a transformative undertaking to leverage the strength and resilience of the human brain to drive innovation, workforce productivity and economic growth.

Part of the DAC Healthcare System Preparedness pillar, the program will operate six sites in the U.S. to help provide timely care for patients experiencing cognitive decline

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve brain health, today announced they will work with Janssen Research & Development, LLC, a Johnson & Johnson company, and Beckman Coulter Diagnostics, two leading pharmaceutical and diagnostics companies, to advance the assay validation of blood-based biomarkers (BBMs) for Alzheimer’s disease for global use in diverse populations.

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve brain health, today announced the launch of its U.S. Early Detection Fellowship Program, an initiative to support health systems in implementing early detection of cognitive impairment and Alzheimer's disease in primary care settings across the United States. As Americans have learned from their experience with cancer, detecting Alzheimer’s in a timely manner is important in extending life and saving healthcare costs. The costs of caring for people living with Alzheimer's and other dementias are projected to reach $360 billion — in 2024 alone — not including the value of unpaid caregiving.